학술논문
Racial and Socioeconomic Equity of Tecovirimat Treatment during the 2022 Mpox Emergency, New York, New York, USA.
Document Type
Article
Author
Source
Subject
*MONKEYPOX
*RACIAL inequality
*INSTITUTIONAL racism
*RACE
*PACIFIC Islanders
*
*
*
*
Language
ISSN
1080-6040
Abstract
We assessed tecovirimat treatment equity for 3,740 mpox patients in New York, New York, USA, during the 2022 mpox emergency; 32.4% received tecovirimat. Treatment rates by race/ethnicity were 38.8% (White), 31.3% (Black/African American), 31.0% (Hispanic/Latino), and 30.1% (Asian/Pacific Islander/other). Future public health emergency responses must prioritize institutional and structural racism mitigation. [ABSTRACT FROM AUTHOR]